Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Website: https://engineering.uark.edu/ Summary of Job Duties: The Postdoctoral Fellow - Biomedical Engineering will continue investigation of cancer nerve crosstalk in both breast cancer and pancreatic
-
candidates. Work Location(s) Number of offers available1Company/InstituteŁukasiewicz – PORT Polish Center for Technology DevelopmentCountryPolandGeofield Contact City Wrocław Website http://www.port.org.pl
-
writing papers on the newly-developed methods and study results. Where to apply Website https://www.academictransfer.com/en/jobs/357243/phd-candidate-multimodal-imagin… Requirements Specific Requirements
-
the Department of Mathematics & Statistics (https://www.reading.ac.uk/maths-and-stats/ ) About the project/work tasks: This position is part of: 19 PhD Fellowships available in Digital Endocrinology in the Marie
-
TUD Dresden University of Technology, as a University of Excellence, is one of the leading and most dynamic research institutions in the country. Founded in 1828, today it is a globally oriented
-
microfluidic technology that cultures cells and tissues inside microfluidic devices to mimic the structure and microenvironment of tissues in the body. These platforms can be used to study disease progression
-
of inflammation in the joints. The project is based on a bed-to-bench-and-back approach , utilising human tissue single-cell and spatial multi-omics , engineered CAR-T cells,human organoids , and unique transgenic
-
/ Bioinformatician – Research Scientist (Temporary) PhD in computational biology, systems biology, bioinformatics, biological engineering, biophysics, mathematics, or related field plus two (2) years of post-degree
-
origin, citizenship, age, disability or protected veteran status. Required Degree Doctorate -Biomedical engineering, stem cells, molecular and cell biology techniques Minimum Requirements PhD in Biomedical
-
engineer (IR) for a 12-month period, aims to develop a new generation of anticancer drugs called degraders (PROteolysis TArgeting Chimeras, PROTACs). These innovative molecules do not simply block a target